Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
Roma, Europe’s Largest Minority, Not Represented At All
The study, by Tufts CSDD, also found that data on minority groups were frequently underreported, and in many cases numbers have not improved with time.
You may also be interested in...
Operational actions, organizational responses and clinical development model improvements led to a 26-month acceleration, on average, in a set of COVID-19 vaccine pivotal trials versus similarly sized pre-pandemic studies, with the database lock and analysis stage delivering dramatic gains, a study by IQVIA Institute indicates. Can these benefits be recapitulated across the portfolio in the post-pandemic era?
Company strategies at improving diversity, equity and inclusion both within their organizations and in the clinical trials they conduct have differed, but building trust is a common theme.
The company is focusing first on gender parity as it navigates around tricky legal frameworks on collecting demographic data.